Redhill Biopharma Ltd operates in the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Redhill Biopharma Ltd with three other
miscellaneous service companies in Middle East:
Arcturus Therapeutics Ltd
sales of 56.79 million Israel Shekels [US$15.92 million]
Collplant Holdings Ltd
(18.03 million Israel Shekels [US$5.06 million]
(6.30 million Israel Shekels [US$1.77 million]
Redhill Biopharma Ltd reported sales of 30.14 million Israel Shekels (US$8.45 million)
December of 2018.
increase of 110.6%
versus 2017, when the company's sales were 14.31 million Israel Shekels.
This was the third consecutive year of growth at Redhill Biopharma Ltd.